What is hypogonadism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Hypogonadism

Hypogonadism is a clinical condition characterized by symptoms and biochemical evidence of testosterone deficiency that impacts multiple organ systems and quality of life. 1

Types of Hypogonadism

Hypogonadism occurs in two main forms:

  • Primary (hypergonadotropic) hypogonadism: Caused by testicular dysfunction, resulting in low testosterone and high gonadotropin levels 1
  • Secondary (hypogonadotropic) hypogonadism: Results from impairment of the hypothalamic-pituitary-gonadal (HPG) axis 1
  • Compensated hypogonadism: Characterized by normal testosterone levels with elevated luteinising hormone production 1
  • Functional hypogonadism: Diagnosed when low testosterone levels occur in the absence of organic alterations in the HPG axis, often as a consequence of comorbidities 1

Clinical Manifestations

Hypogonadism presents with various symptoms affecting multiple systems:

  • Sexual symptoms: Diminished libido, erectile dysfunction 1
  • Physical symptoms: Reduced muscle mass and strength, increased body fat, diminished bone density, anemia 1
  • Psychological symptoms: Diminished energy, increased fatigue, depressed mood, impaired cognition 1

Etiology

Primary Hypogonadism Causes

  • Congenital disorders: Chromosomal abnormalities (e.g., XX male, 47 XYY syndrome), Down syndrome, Noonan syndrome 1
  • Developmental disorders: Uncorrected cryptorchidism, bilateral congenital anorchia 1
  • Acquired disorders: Testicular trauma, orchitis, radiation damage 2

Secondary Hypogonadism Causes

  • Congenital disorders: Idiopathic hypogonadotropic hypogonadism, Kallmann syndrome, Prader-Willi syndrome 1
  • Acquired disorders: Pituitary tumors, traumatic brain injury, radiation to the brain 1
  • Drug-induced: Opiates, GnRH agonists/antagonists, glucocorticoids, estrogens, anabolic steroids 1

Systemic Conditions Associated with Hypogonadism

  • Metabolic disorders: Type 2 diabetes mellitus, metabolic syndrome 1, 3
  • Chronic diseases: HIV infection, chronic organ failure, chronic inflammatory arthritis 1, 3
  • Other conditions: Cushing syndrome, eating disorders, endurance exercise, acute and critical illness, aging 1

Diagnosis

Diagnosis of hypogonadism requires:

  • Clinical symptoms: Assessment of sexual function, energy levels, mood, and physical changes 1, 4
  • Biochemical testing: Low serum testosterone levels 1
  • Additional hormonal assessment: Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to differentiate between primary and secondary hypogonadism 4, 5

Treatment Considerations

Treatment depends on the type of hypogonadism and patient goals:

  • Testosterone replacement therapy (TRT): Standard treatment for most forms of hypogonadism 2, 6
  • Gonadotropin therapy: Alternative for men wishing to preserve fertility 6
  • Treatment of underlying conditions: Particularly important in functional hypogonadism 1, 3

Monitoring and Potential Risks

Patients on testosterone therapy require monitoring for:

  • Erythrocytosis: Risk varies by administration route (3-18% with transdermal, up to 44% with injections) 1
  • Cardiovascular effects: Current evidence suggests neutral or possibly beneficial effects 1
  • Prostate health: Requires long-term monitoring 1
  • Other side effects: Fluid retention, sleep apnea, gynecomastia, skin reactions, and testicular atrophy 1

Hypogonadism significantly impacts mortality, morbidity, and quality of life, making proper diagnosis and treatment essential for optimal patient outcomes 1, 7, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Male hypogonadism in systemic disease.

Endocrinology and metabolism clinics of North America, 2007

Research

Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis.

International journal of impotence research, 2006

Research

Hypogonadism: Its Prevalence and Diagnosis.

The Urologic clinics of North America, 2016

Research

Male and Female Hypogonadism.

The Nursing clinics of North America, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.